Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 13, 2011Expert Opinion on Biological Therapy

A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

TBTrevor J. BaylissJSJeff SmithMSMichael Schuster

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bayliss et al. (2011) studied this question.

synapsesocial.com/papers/69ffa754ef8139f8ff776b0ehttps://doi.org/10.1517/14712598.2011.627850
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Expression of activated and latent signal transducer and activator of transcription 3 in 303 non-small cell lung carcinomas and 44 malignant mesotheliomas: possible role for chemotherapeutic intervention.2007 · 26 citations
  2. 2Interleukin‐6 is the major regulator of acute phase protein synthesis in adult human hepatocytes1989 · 910 citations
  3. 3IL-6 induces neuroendocrine dedifferentiation and cell proliferation in non-small cell lung cancer cells2005 · 72 citations
  4. 4IL-6 involvement in epithelial cancers2007 · 271 citations
  5. 5Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients.1995 · 219 citations